Results 91 to 100 of about 68,797,773 (271)

ШАПЕРОМ: ИСТОРИЧЕСКАЯ ПЕРСПЕКТИВА И СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ

open access: yesРоссийские биомедицинские исследования
Жизненный цикл клеток сопровождается постоянным синтезом, транспортом и деградацией полипептидных цепей — белков и сигнальных последовательностей. Каждая полипептидная цепь обладает четырьмя уровнями структуры, и принятие ею правильной пространственной ...
Вячеслав Сергеевич Федоров   +2 more
doaj   +1 more source

Evaluation of Digital Technologies for Home‐Based Assessment in People With Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller   +14 more
wiley   +1 more source

ПАТОФИЗИОЛОГИЧЕСКИЕ ОСОБЕННОСТИ ИЗМЕНЕНИЯ ГЛИАЛЬНЫХ КЛЕТОК И МАРКЕРЫ ПОВРЕЖДЕНИЯ ТКАНЕЙ МОЗГА ПРИ ЧЕРЕПНО-МОЗГОВОЙ ТРАВМЕ

open access: yesРоссийские биомедицинские исследования
Черепно-мозговая травма (ЧМТ) является основной причиной смертности и психических расстройств среди неврологической патологии. У многих пациентов ЧМТ оставляет долгосрочные последствия, которые могут быть связаны как с легкими нарушениями когнитивных ...
Анна Алексеевна Прохорычева   +2 more
doaj   +1 more source

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers   +19 more
wiley   +1 more source

МЕХАНИЗМЫ МИГРАЦИИ МЕЗЕНХИМАЛЬНЫХ СТВОЛОВЫХ КЛЕТОК И ВОЗМОЖНЫЕ СТРАТЕГИИ ИХ УЛУЧШЕНИЯ

open access: yesРоссийские биомедицинские исследования
В последние десятилетия накапливается все больше данных о механизмах обновления и регенерации тканей, которые были бы невозможны без участия стволовых клеток.
Родион Владимирович Кораблев   +8 more
doaj   +1 more source

Interaction of Intraprocedural Antiplatelets and Intravenous Thrombolysis in Acute Intracranial Stenting: RESISTANT Registry Subanalysis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction/Objective Acute intracranial stenting during endovascular thrombectomy (EVT) for ischemic stroke requires intraprocedural antiplatelet therapy (APT) to maintain patency. However, the hemorrhagic risk of combining APT with intravenous thrombolysis (IVT) remains uncertain.
Aaron Rodriguez‐Calienes   +75 more
wiley   +1 more source

Digital Cognitive Phenotyping for Differential Diagnosis and Monitoring in Neurological Conditions

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To assess the utility, accessibility, and equivalence to supervised scales of online cognitive assessment in older individuals with cognitive impairment. Methods Patients with Alzheimer's disease (AD, n = 31), idiopathic normal pressure hydrocephalus (iNPH, n = 26), and traumatic brain injury (TBI, n = 23) completed online cognitive ...
Martina Del Giovane   +10 more
wiley   +1 more source

Whistleblowing: an ethical dilemma

open access: yesРоссийские биомедицинские исследования, 2016
Because most organizations depend on computer systems that electronically store important data to perform crucial business functions, the integrity of these information systems is paramount. Securing company systems, however, is not always an easy task.
Raj Yagna
doaj  

Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy